Brokerages Set KORU Medical Systems, Inc. (NASDAQ:KRMD) PT at $6.50

Shares of KORU Medical Systems, Inc. (NASDAQ:KRMD) have been given an average recommendation of “Moderate Buy” by the six brokerages that are currently covering the company, MarketBeat reports. One research analyst has rated the stock with a sell recommendation, one has given a hold recommendation and four have issued a buy recommendation on the company. The average 12-month price target among brokerages that have issued a report on the stock in the last year is $6.50.

Several brokerages have recently weighed in on KRMD. Craig Hallum restated a “buy” rating and set a $7.00 price objective on shares of KORU Medical Systems in a research report on Tuesday, January 13th. B. Riley Financial increased their target price on shares of KORU Medical Systems from $7.00 to $8.00 and gave the company a “buy” rating in a research report on Friday, March 13th. Canaccord Genuity Group reiterated a “buy” rating and set a $6.00 price target on shares of KORU Medical Systems in a research note on Friday, March 13th. Weiss Ratings reissued a “sell (d-)” rating on shares of KORU Medical Systems in a research report on Thursday, January 22nd. Finally, Wall Street Zen downgraded shares of KORU Medical Systems from a “strong-buy” rating to a “buy” rating in a research note on Saturday, March 14th.

Institutional Trading of KORU Medical Systems

A number of large investors have recently made changes to their positions in the company. Police & Firemen s Retirement System of New Jersey acquired a new position in KORU Medical Systems during the second quarter worth approximately $30,000. BNP Paribas Financial Markets boosted its holdings in shares of KORU Medical Systems by 52.1% in the third quarter. BNP Paribas Financial Markets now owns 10,148 shares of the company’s stock valued at $39,000 after acquiring an additional 3,478 shares during the period. Lazard Asset Management LLC purchased a new position in shares of KORU Medical Systems during the second quarter worth approximately $59,000. Intech Investment Management LLC purchased a new position in shares of KORU Medical Systems during the second quarter worth approximately $73,000. Finally, Occudo Quantitative Strategies LP acquired a new position in shares of KORU Medical Systems in the 4th quarter valued at $127,000. 58.60% of the stock is owned by institutional investors and hedge funds.

KORU Medical Systems Stock Performance

KRMD opened at $4.22 on Friday. KORU Medical Systems has a one year low of $1.86 and a one year high of $6.61. The company has a market cap of $195.68 million, a P/E ratio of -70.33 and a beta of 0.47. The business’s 50-day simple moving average is $4.83 and its 200-day simple moving average is $4.82.

KORU Medical Systems (NASDAQ:KRMD) last posted its earnings results on Thursday, March 12th. The company reported ($0.01) earnings per share for the quarter, topping the consensus estimate of ($0.02) by $0.01. The firm had revenue of $10.90 million during the quarter, compared to analysts’ expectations of $10.90 million. KORU Medical Systems had a negative return on equity of 15.90% and a negative net margin of 6.41%. As a group, analysts predict that KORU Medical Systems will post -0.13 earnings per share for the current fiscal year.

About KORU Medical Systems

KORU Medical Systems, Inc develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria. Its products include the FREEDOM60 syringe infusion system, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing products.